Devon Cimino

Researchers evaluated the epidemiologic, clinical, and household transmission characteristics of infection with the SARS-CoV-2 Omicron variant among children.

The World Health Organization describes new recommended treatments for COVID-19 in the 11th update to their living guideline.

Investigators collected specimens from the residence of 2 individuals with confirmed monkeypox infection to assess the potential for indirect transmission of monkeypox virus in household environments.

A State Disaster Emergency was declared in New York due to evidence of circulating poliovirus.

Researchers assessed the rate of COVID-19 reinfection during the Omicron wave among individuals in Iceland.

The World Health Organization’s emergency committee met to discuss the multi-country outbreak of monkeypox.

Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.

Researchers evaluated the effect of adjuvant colchicine with standard therapy among patients with moderate and severe COVID-19 infection.

In this ninth update to the living guideline on COVID-19 therapeutics, the World Health Organization evaluates the use of nirmatrelvir/ritonavir for nonsevere COVID-19 and revises prior recommendations regarding the use of remdesivir.

In this Q&A, Erica Johnson, MD, discussed the transition from pandemic to endemic in regard to COVID-19 infection.

Researchers conducted a study that compared voter turnout between physicians and the general population for US elections held between 2000 and 2020.

In this Q&A, Erica Johnson, MD, provides insight into the new oral antiviral medications that may soon be approved for the treatment of COVID-19.

Researchers sought to assess the risk for COVID-19-related hospitalization or death among patients with immune-mediated inflammatory diseases receiving treatment with tumor necrosis factor inhibitors.